Netherton syndrome: skin inflammation and allergy by loss of protease inhibition

@article{Hovnanian2013NethertonSS,
  title={Netherton syndrome: skin inflammation and allergy by loss of protease inhibition},
  author={A. Hovnanian},
  journal={Cell and Tissue Research},
  year={2013},
  volume={351},
  pages={289-300}
}
  • A. Hovnanian
  • Published 2013
  • Biology, Medicine
  • Cell and Tissue Research
  • Netherton syndrome (NS) is a rare autosomal recessive skin disease with severe skin inflammation and scaling, a specific hair shaft defect and constant allergic manifestations. NS is caused by loss-of-function mutations in SPINK5 (serine protease inhibitor of kazal type 5) encoding LEKTI-1 (lympho-epithelial kazal type related inhibitor type 5) expressed in stratified epithelia. In vitro and in vivo studies in murine models and in NS patients have cast light on the pathogenesis of the disease… CONTINUE READING
    112 Citations
    Netherton syndrome: defective kallikrein inhibition in the skin leads to skin inflammation and allergy
    • 41
    Genetic activation of Nrf2 reduces cutaneous symptoms in a murine model of Netherton syndrome
    • 1
    • PDF
    Physiological and pathological roles of kallikrein-related peptidases in the epidermis.
    • M. Kishibe
    • Medicine
    • Journal of dermatological science
    • 2019
    • 7
    Multifaceted Analyses of Epidermal Serine Protease Activity in Patients with Atopic Dermatitis
    • 1
    • PDF
    TNF-α and IL-17A induce the expression of lympho-epithelial Kazal-type inhibitor in epidermal keratinocytes.
    New mutation leading to the full variety of typical features of the Netherton syndrome
    • 3

    References

    SHOWING 1-10 OF 103 REFERENCES
    Par2 inactivation inhibits early production of TSLP, but not cutaneous inflammation, in Netherton syndrome adult mouse model.
    • 85
    Kallikrein 5 induces atopic dermatitis–like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome
    • 386
    • PDF
    Netherton syndrome: new advances in the clinic, disease mechanism and treatment
    • 10
    • Highly Influential
    The 420K LEKTI variant alters LEKTI proteolytic activation and results in protease deregulation: implications for atopic dermatitis.
    • 67
    • PDF
    SPINK5 and Netherton syndrome: novel mutations, demonstration of missing LEKTI, and differential expression of transglutaminases.
    • 94
    Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome.
    • 152
    Comèl-Netherton syndrome defined as primary immunodeficiency.
    • 111
    • Highly Influential
    Proteolytic activation cascade of the Netherton syndrome-defective protein, LEKTI, in the epidermis: implications for skin homeostasis.
    • 60
    Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessing.
    • 97
    • PDF
    rAAV2-mediated restoration of LEKTI in LEKTI-deficient cells from Netherton patients.
    • 21